{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T21:49:30Z","timestamp":1774820970421,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,29]]},"DOI":"10.7759\/cureus.106080","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T21:44:31Z","timestamp":1774820671000},"source":"Crossref","is-referenced-by-count":0,"title":["Off-Label Use of Gabapentinoids in Non-diabetic Patients Referred to a Rheumatology Clinic: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Gowri","family":"Renganathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Alhariri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nibesh","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrilekha","family":"Sairam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S493542","article-title":"Prescribing patterns and off-label use of gabapentinoid agents at Dhulikhel Hospital, Nepal: A cross-sectional study","volume":"17","author":"Adhikari S","year":"2024","unstructured":"Adhikari S, Bista D, Shrestha R, Woods D. Prescribing patterns and off-label use of gabapentinoid agents at Dhulikhel Hospital, Nepal: A cross-sectional study. J Pain Res. 2024, 17:4377-91. 10.2147\/JPR.S493542","journal-title":"J Pain Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12931","article-title":"Gabapentin in headache disorders: what is the evidence?","volume":"17","author":"Perloff MD","year":"2016","unstructured":"Perloff MD, Berlin RK, Gillette M, Petersile MJ, Kurowski D. Gabapentin in headache disorders: what is the evidence?. Pain Med. 2016, 17:162-71. 10.1111\/pme.12931","journal-title":"Pain Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1370\/afm.3052","article-title":"Update to gabapentinoid use in the United States, 2002-2021","volume":"22","author":"Johansen ME","year":"2024","unstructured":"Johansen ME, Maust DT. Update to gabapentinoid use in the United States, 2002-2021. Ann Fam Med. 2024, 22:45-9. 10.1370\/afm.3052","journal-title":"Ann Fam Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01386-6","article-title":"Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale","volume":"27","author":"Hong JS","year":"2022","unstructured":"Hong JS, Atkinson LZ, Al-Juffali N, et al.. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Mol Psychiatry. 2022, 27:1339-49. 10.1038\/s41380-021-01386-6","journal-title":"Mol Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1178221818801311","article-title":"Gabapentin for off-label use: evidence-based or cause for concern?","volume":"12","author":"Peckham AM","year":"2018","unstructured":"Peckham AM, Evoy KE, Ochs L, Covvey JR. Gabapentin for off-label use: evidence-based or cause for concern?. Subst Abuse. 2018, 12:1178221818801311. 10.1177\/1178221818801311","journal-title":"Subst Abuse"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00513-z","article-title":"Gabapentinoids for pruritus in older adults: a narrative review","volume":"11","author":"Sreekantaswamy SA","year":"2021","unstructured":"Sreekantaswamy SA, Mollanazar N, Butler DC. Gabapentinoids for pruritus in older adults: a narrative review. Dermatol Ther (Heidelb). 2021, 11:669-79. 10.1007\/s13555-021-00513-z","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002369","article-title":"Benefits and safety of gabapentinoids in chronic low back pain: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Shanthanna H","year":"2017","unstructured":"Shanthanna H, Gilron I, Rajarathinam M, et al.. Benefits and safety of gabapentinoids in chronic low back pain: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2017, 14:e1002369. 10.1371\/journal.pmed.1002369","journal-title":"PLoS Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-23951","article-title":"Off-label medication use: a double-edged sword","volume":"25","author":"Agarwal V","year":"2021","unstructured":"Agarwal V. Off-label medication use: a double-edged sword. Indian J Crit Care Med. 2021, 25:845-6. 10.5005\/jp-journals-10071-23951","journal-title":"Indian J Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3245","article-title":"Often off-label: questionable gabapentinoid use noted at hospital admission warrants deprescribing","volume":"14","author":"Lam K","year":"2019","unstructured":"Lam K, Rochon PA, Steinman MA. Often off-label: questionable gabapentinoid use noted at hospital admission warrants deprescribing. J Hosp Med. 2019, 14:579-80. 10.12788\/jhm.3245","journal-title":"J Hosp Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study","volume":"14","author":"Gomes T","year":"2017","unstructured":"Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2017, 14:e1002396. 10.1371\/journal.pmed.1002396","journal-title":"PLoS Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009, 42:377-81.  10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al.. The REDCap consortium: Building an international community of software partners. J Biomed Inform. 2019, 95:103208. 10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup NB","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, et al.. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015, 14:162-73. 10.1016\/S1474-4422(14)70251-0","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/01.ana.0000151407.62650.51","article-title":"Evaluation of the optimal preemptive dose of gabapentin for postoperative pain relief after lumbar diskectomy: a randomized, double-blind, placebo-controlled study","volume":"17","author":"Pandey CK","year":"2005","unstructured":"Pandey CK, Navkar DV, Giri PJ, et al.. Evaluation of the optimal preemptive dose of gabapentin for postoperative pain relief after lumbar diskectomy: a randomized, double-blind, placebo-controlled study. J Neurosurg Anesthesiol. 2005, 17:65-8. 10.1097\/01.ana.0000151407.62650.51","journal-title":"J Neurosurg Anesthesiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e497","article-title":"Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis","volume":"344","author":"Pinto RZ","year":"2012","unstructured":"Pinto RZ, Maher CG, Ferreira ML, et al.. Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis. BMJ. 2012, 344:e497. 10.1136\/bmj.e497","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33832-x","article-title":"Proportion of neuropathic pain in the back region in chronic low back pain patients - a multicenter investigation","volume":"8","author":"Li J","year":"2018","unstructured":"Li J, He J, Li H, et al.. Proportion of neuropathic pain in the back region in chronic low back pain patients - a multicenter investigation. Sci Rep. 2018, 8:16537. 10.1038\/s41598-018-33832-x","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.aprim.2021.102144","article-title":"A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain","volume":"54","author":"Gim\u00e9nez-Campos MS","year":"2022","unstructured":"Gim\u00e9nez-Campos MS, Pimenta-Fermisson-Ramos P, D\u00edaz-Cambronero JI, Carbonell-Sanch\u00eds R, L\u00f3pez-Briz E, Ru\u00edz-Garc\u00eda V. A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain. Aten Primaria. 2022, 54:102144. 10.1016\/j.aprim.2021.102144","journal-title":"Aten Primaria"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236\u2009379 survivors of COVID-19: a retrospective cohort study using electronic health records","volume":"8","author":"Taquet M","year":"2021","unstructured":"Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236\u2009379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021, 8:416-27. 10.1016\/S2215-0366(21)00084-5","journal-title":"Lancet Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.15r01821","article-title":"Gabapentin therapy in psychiatric disorders: a systematic review","volume":"17","author":"Berlin RK","year":"2015","unstructured":"Berlin RK, Butler PM, Perloff MD. Gabapentin therapy in psychiatric disorders: a systematic review. Prim Care Companion CNS Disord. 2015, 17:10.4088\/PCC.15r01821","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00228","article-title":"Use of gabapentin in the treatment of substance use and psychiatric disorders: a systematic review","volume":"10","author":"Ahmed S","year":"2019","unstructured":"Ahmed S, Bachu R, Kotapati P, et al.. Use of gabapentin in the treatment of substance use and psychiatric disorders: a systematic review. Front Psychiatry. 2019, 10:228. 10.3389\/fpsyt.2019.00228","journal-title":"Front Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31793-8","article-title":"Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis","volume":"393","author":"Slee A","year":"2019","unstructured":"Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019, 393:768-77. 10.1016\/S0140-6736(18)31793-8","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2020.6","article-title":"Pharmacological treatments for social anxiety disorder in adults: a systematic review and network meta-analysis","volume":"32","author":"Williams T","year":"2020","unstructured":"Williams T, McCaul M, Schwarzer G, Cipriani A, Stein DJ, Ipser J. Pharmacological treatments for social anxiety disorder in adults: a systematic review and network meta-analysis. Acta Neuropsychiatr. 2020, 32:169-76. 10.1017\/neu.2020.6","journal-title":"Acta Neuropsychiatr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000554","article-title":"A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component","volume":"157","author":"Atkinson JH","year":"2016","unstructured":"Atkinson JH, Slater MA, Capparelli EV, et al.. A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component. Pain. 2016, 157:1499-507. 10.1097\/j.pain.0000000000000554","journal-title":"Pain"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy KE","year":"2017","unstructured":"Evoy KE, Morrison MD, Saklad SR. Abuse and misuse of pregabalin and gabapentin. Drugs. 2017, 77:403-26. 10.1007\/s40265-017-0700-x","journal-title":"Drugs"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith RV","year":"2016","unstructured":"Smith RV, Havens JR, Walsh SL. Gabapentin misuse, abuse and diversion: a systematic review. Addiction. 2016, 111:1160-74. 10.1111\/add.13324","journal-title":"Addiction"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.21962.2","article-title":"Respiratory concerns of gabapentin and pregabalin: what does it mean to the pharmacovigilance systems in developing countries?","volume":"9","author":"Shrestha S","year":"2020","unstructured":"Shrestha S, Palaian S. Respiratory concerns of gabapentin and pregabalin: what does it mean to the pharmacovigilance systems in developing countries?. F1000Res. 2020, 9:32. 10.12688\/f1000research.21962.2","journal-title":"F1000Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385372-off-label-use-of-gabapentinoids-in-non-diabetic-patients-referred-to-a-rheumatology-clinic-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T21:44:31Z","timestamp":1774820671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385372-off-label-use-of-gabapentinoids-in-non-diabetic-patients-referred-to-a-rheumatology-clinic-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.106080","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,29]]}}}